PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Cancer 1,053,491 Disease Target CYR61 539 138 0.01 -0.86 0.26 0.58
Cancer 1,053,491 Disease Drug Azacitidine (Vidaza)- FDA 47 12 0.00 -0.86 0.26 0.56
Cancer 1,053,491 Disease Disease Asthenia 3,478 877 0.01 -0.86 0.25 0.59
Cancer 1,053,491 Disease Target EPHB2 385 97 0.00 -0.86 0.25 0.57
Cancer 1,053,491 Disease Drug Alemtuzumab (Campath)- FDA 32 8 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Target 4-1BB Receptor 20 5 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Drug Adcetris (Brentuximab Vedotin)- FDA 12 3 0.00 -0.87 0.25 0.56
Cancer 1,053,491 Disease Drug Acarbose (Precose)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Ck-beta-11 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Xaa-Pro Dipeptidase 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Egl Nine Homolog 1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Drug Ancobon (Flucytosine)- FDA 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target Melatonin Receptor Type 1a 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Target CCBL1 4 1 0.00 -0.87 0.25 0.55
Cancer 1,053,491 Disease Disease Xerostomia 3,054 759 0.01 -0.87 0.25 0.59
Cancer 1,053,491 Disease Disease Mesothelioma 11,198 2,734 0.03 -0.87 0.24 0.60
Cancer 1,053,491 Disease Target Glutathione Peroxidase 2 67 16 0.00 -0.87 0.24 0.56
Cancer 1,053,491 Disease Target Cox-2 21,583 5,031 0.03 -0.87 0.23 0.61
Cancer 1,053,491 Disease Target DNA-damage-inducible transcript 3 30 7 0.00 -0.88 0.23 0.56
Cancer 1,053,491 Disease Disease Glioblastoma 17,933 4,092 0.03 -0.88 0.23 0.61
Cancer 1,053,491 Disease Target BMPR1A 279 63 0.00 -0.88 0.23 0.57
Cancer 1,053,491 Disease Target Cytokeratin 18 1,108 249 0.01 -0.88 0.22 0.58
Cancer 1,053,491 Disease Target DAPK2 27 6 0.00 -0.88 0.22 0.56
Cancer 1,053,491 Disease Target CXCL4/PF4 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Target CD254 9 2 0.00 -0.88 0.22 0.55
Cancer 1,053,491 Disease Disease Nausea 42,627 9,149 0.04 -0.88 0.21 0.62
Cancer 1,053,491 Disease Target Multidrug Resistance-Associated Protein 2 462 100 0.00 -0.89 0.22 0.57
Cancer 1,053,491 Disease Target CD137 474 102 0.00 -0.89 0.22 0.57
Cancer 1,053,491 Disease Target Annexin A1 406 86 0.00 -0.89 0.21 0.57
Cancer 1,053,491 Disease Target EPHB3 118 25 0.00 -0.89 0.21 0.56
Cancer 1,053,491 Disease Disease Gastritis 17,713 3,549 0.03 -0.89 0.20 0.60
Cancer 1,053,491 Disease Target Galectin-1 1,131 229 0.01 -0.89 0.20 0.57
Cancer 1,053,491 Disease Target EPHA3 140 28 0.00 -0.89 0.20 0.56
Cancer 1,053,491 Disease Target 4-1BB Ligand 135 27 0.00 -0.89 0.20 0.56
Cancer 1,053,491 Disease Drug Dragonamide 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Target Nad-Dependent Protein Deacetylase Sirtuin-1 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Target CCL27/CTACK 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Target Small Inducible Cytokine A2 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Disease Carcinoma Endometrial 5 1 0.00 -0.89 0.20 0.55
Cancer 1,053,491 Disease Target EGF 27,487 5,238 0.03 -0.90 0.19 0.61
Cancer 1,053,491 Disease Target DJ-1/PARK7 21 4 0.00 -0.90 0.19 0.55
Cancer 1,053,491 Disease Target ANGPTL4 289 55 0.00 -0.90 0.19 0.56
Cancer 1,053,491 Disease Target Glutathione Peroxidase 3 132 25 0.00 -0.90 0.19 0.56
Cancer 1,053,491 Disease Drug Actos (Pioglitazone Hydrochloride)- FDA 38 7 0.00 -0.90 0.18 0.55
Cancer 1,053,491 Disease Target Beta-R1 38 7 0.00 -0.90 0.18 0.55
Cancer 1,053,491 Disease Drug Aphrodyne (Yohimbine)- FDA 11 2 0.00 -0.90 0.18 0.55
Cancer 1,053,491 Disease Target AFP 9,751 1,749 0.02 -0.91 0.18 0.59
Cancer 1,053,491 Disease Disease Menopause 19,680 3,498 0.02 -0.91 0.18 0.60
Cancer 1,053,491 Disease Disease Enlarged Prostate 388 70 0.00 -0.91 0.18 0.56
Cancer 1,053,491 Disease Target ACY1 51 9 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Target CCL14 34 6 0.00 -0.91 0.18 0.55
Cancer 1,053,491 Disease Target EG-VEGF 63 11 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target Endoglin 1,333 232 0.01 -0.91 0.17 0.57
Cancer 1,053,491 Disease Disease Mucus In Stool 23 4 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target BMX 185 32 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target CXCL3 145 25 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target ENO2 87 15 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Apo D 105 18 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target Glutathione S-Transferase A1 111 19 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Target ETS1 539 92 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Disease Warts 5,574 942 0.01 -0.91 0.17 0.58
Cancer 1,053,491 Disease Target Steroid 5-Alpha-Reductase 293 49 0.00 -0.91 0.17 0.56
Cancer 1,053,491 Disease Drug Arranon (Nelarabine)- FDA 12 2 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target E9 protein 6 1 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Drug Acular (Ketorolac Tromethamine)- FDA 6 1 0.00 -0.91 0.17 0.55
Cancer 1,053,491 Disease Target ERK1 18,374 2,955 0.02 -0.91 0.16 0.59
Cancer 1,053,491 Disease Disease Brain Tumors 16,749 2,693 0.02 -0.91 0.16 0.59
Cancer 1,053,491 Disease Target Signal Transducer And Activator Of Transcription 5b 82 13 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Target CXCL7 76 12 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Drug Aralen (Chloroquine)- FDA 19 3 0.00 -0.92 0.16 0.55
Cancer 1,053,491 Disease Disease Skin Rash 3,684 578 0.01 -0.92 0.16 0.58
Cancer 1,053,491 Disease Disease Gynecomastia 2,594 407 0.01 -0.92 0.16 0.57
Cancer 1,053,491 Disease Target CCL18 256 40 0.00 -0.92 0.16 0.56
Cancer 1,053,491 Disease Target Methylenetetrahydrofolate Reductase 3,573 555 0.01 -0.92 0.16 0.58
Cancer 1,053,491 Disease Target Hyaluronidase-1 52 8 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target AURKC 26 4 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target Chorionic Gonadotropin beta 936 141 0.00 -0.92 0.15 0.56
Cancer 1,053,491 Disease Target Macrophage Metalloelastase 100 15 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Drug Dracorhodin 20 3 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Drug Antabuse (Disulfiram)- FDA 27 4 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target EPHB1 137 20 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Target CLK1 62 9 0.00 -0.92 0.15 0.55
Cancer 1,053,491 Disease Disease Postgastrectomy 829 120 0.00 -0.92 0.14 0.56
Cancer 1,053,491 Disease Target FABP1 90 13 0.00 -0.92 0.14 0.55
Cancer 1,053,491 Disease Target AMY2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target CAMK2B 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target Alpha Platelet-Derived Growth Factor Receptor 21 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Drug Abciximab (ReoPro)- FDA 7 1 0.00 -0.93 0.14 0.54
Cancer 1,053,491 Disease Drug Kabiramide C 7 1 0.00 -0.93 0.14 0.54
Cancer 1,053,491 Disease Disease Leukemias 14,152 1,978 0.02 -0.93 0.14 0.59
Cancer 1,053,491 Disease Target CCL21 808 113 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target Retinoic Acid Receptor Alpha 1,068 149 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Disease Andropause 317 44 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target CA 50 1,293 178 0.00 -0.93 0.14 0.56
Cancer 1,053,491 Disease Target DC-CK1 22 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Drug Drupanin 22 3 0.00 -0.93 0.14 0.55
Cancer 1,053,491 Disease Target ANGPT2 105 14 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Drug Kaempferide 60 8 0.00 -0.93 0.13 0.55
Cancer 1,053,491 Disease Disease Multiple Myeloma 24,594 3,199 0.02 -0.93 0.13 0.59
Cancer 1,053,491 Disease Target Peroxisome Proliferator-Activated Receptor Delta 355 47 0.00 -0.93 0.13 0.56